Uterin artery embolisation: a rescuer in cervical ectopic pregnancy

2021 ◽  
Vol 14 (9) ◽  
pp. e244623
Author(s):  
Abha Majumdar ◽  
Bhawani Shekhar ◽  
Ambarish Satwik

Cervical ectopic pregnancy is an extremely rare form of ectopic pregnancy with potential risk of massive bleeding and associated morbidity. Managing this condition is challenging for clinicians due to the serious risk to patient and dilemma faced in deciding the appropriate management plan. This case report describes the role of uterine artery embolisation in managing a case of cervical ectopic pregnancy with heavy bleeding per vaginum post methotrexate treatment with falling beta human chorionic gonadotropin (HCG) levels. It highlights the unpredictable nature of this condition and need for prompt intervention in an emergency situation.

Hysteroscopy ◽  
2017 ◽  
pp. 171-179
Author(s):  
Salvatore Giovanni Vitale ◽  
Agnese Maria Chiara Rapisarda ◽  
Antonio Simone Laganà

2015 ◽  
Vol 1 (1) ◽  
pp. 22
Author(s):  
Slavcho Tomov ◽  
Grigor Gortchev ◽  
Lachezar Tantchev ◽  
Margarita Nikolova ◽  
Savelina Popovska

Author(s):  
Munjal J. Pandya ◽  
Neha V. Ninama ◽  
Chirag V. Thummar ◽  
Meet K. Patel

Background: Ectopic pregnancy is an acute emergency in obstetric if not timely diagnosed and timely treated. Ectopic pregnancy is leading cause of death in first trimester. Ectopic pregnancy can be managed surgically or medically. Medical management with Methotrexate administration avoids anesthesia in surgery, is cost effective and also offers success rate comparable to surgical management. Aim and objectives were to study the role of methotrexate in ectopic pregnancyMethods: This will be a retrospective observational study conducted in Obstetrics and Gynecology department of AMC MET medical college. Study group constitutes of 30 females with ectopic pregnancy. Preliminary blood investigations, ultrasonography and beta-human chorionic gonadotropin (b-hcg) level will be tested. Patients will be treated with single dose of methotrexate 50 mg/M2. Follow up b-hcg level will be done after 48 hours. Response and tolerance to methotrexate will be monitored.Results: The success rate of methotrexate therapy in our study was 83.33% (n=25) and 16.66% (n=5) required surgical intervention with tubal ruptured and abdominal pain.Conclusions: Methotrexate treatment of ectopic pregnancies is safe and effective with no major side effects. It has the advantage of tubal conservation and saves patients from surgical intervention.


Sign in / Sign up

Export Citation Format

Share Document